Image
17.11.2023
Bristol paramedic raises over £4,000 by running 100km on World Diabet...
A 24-year-old Paramedic from Bristol took on an epic fundraising challenge on World Diabetes Day (14th No...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more